Our lab previously utilized the MMTV-v-Ha-ras (MMTV-Hras) transgenic mouse mammary/salivary tumor model [45] crossed with p53 null mice [3] to study the influence of p53 loss on tumorigenesis and tumor properties. This evidence concerns the gene HRAS and neoplasm.